Mazal Shaul

Title: The Innovative Contributions of Mazal Shaul

Introduction

Mazal Shaul is a notable inventor based in Azur, Israel. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for treating central nervous system (CNS) disorders. With a total of 2 patents, his work showcases a commitment to advancing medical treatments.

Latest Patents

Mazal Shaul's latest patents include an acid addition salt of a nortriptyline-GABA conjugate and a process of preparing the same. This patent discloses a novel crystalline form of a fumaric acid addition salt of a nortriptyline-GABA conjugate, along with processes for its preparation. The applications of this conjugate are particularly relevant for treating CNS disorders and pain management. Another significant patent involves crystalline forms of the tri-mesylate salt of perphenazine-GABA and the process of producing the same. This patent describes a unique crystalline form characterized by a specific XRPD pattern and a DSC exhibiting an endothermic peak at a high temperature. The process of preparing perphenazine 4-aminobutyrate trimesylate is also highlighted, showcasing a single-step synthesis that yields a highly pure product.

Career Highlights

Throughout his career, Mazal Shaul has worked with esteemed institutions such as Ramot at Tel Aviv University Ltd. and Bar-Ilan University. His research has focused on innovative approaches to drug development, particularly in the realm of CNS treatments.

Collaborations

Mazal has collaborated with Ada Rephaeli, a fellow researcher, to further enhance the impact of their work in the pharmaceutical field.

Conclusion

Mazal Shaul's contributions to pharmaceutical innovations demonstrate his dedication to improving treatment options for CNS disorders. His patents reflect a blend of creativity and scientific rigor, positioning him as a significant figure in the field of medical research.